Evidence map›Paper›PMID 41862640›Full record

ArticleThe EMBO journal2026

ALS mutations disrupt self-association between the ubiquilin STI1 hydrophobic groove and internal placeholder sequences.

Joan Onwunma, Saeed Binsabaan, Shawn P Allen, Sachini R Thanthirige, Deepika Gaur, Banumathi Sankaran, Matthew L Wohlever

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Joan Onwunma *Department of Chemistry & Biochemistry, University of Toledo, Toledo, OH, USA.
Saeed Binsabaan *Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0009-0009-6590-0564
Shawn P Allen *Department of Chemistry & Biochemistry, University of Toledo, Toledo, OH, USA.ORCID http://orcid.org/0000-0002-3025-1076
Sachini R ThanthirigeDepartment of Chemistry & Biochemistry, University of Toledo, Toledo, OH, USA.ORCID http://orcid.org/0009-0009-3172-9906
Deepika GaurDepartment of Chemistry & Biochemistry, University of Toledo, Toledo, OH, USA.ORCID http://orcid.org/0000-0002-4091-1680
Banumathi SankaranLawrence Berkeley National Lab, Berkeley Center for Structural Biology, Molecular Biophysics and Integrated Bioimaging, Berkeley, CA, USA.
Matthew L WohleverDepartment of Chemistry & Biochemistry, University of Toledo, Toledo, OH, USA. wohlever@pitt.edu.ORCID http://orcid.org/0000-0002-9406-3410

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Gregory L Hura · 2017 to 2026
$28.6M
HHS | National Institutes of Health (NIH) P30 GM124169-01HHS | National Institutes of Health (NIH) R35 GM137904-01S2National Science Foundation (NSF) CAREER Award 2343131NIGMS NIH HHS P30 GM124169
6 · The paper itself

Abstract

Ubiquilins are molecular chaperones that play multifaceted roles in proteostasis, with point mutations in UBQLN2 leading to altered phase-separation properties and amyotrophic lateral sclerosis (ALS). Our mechanistic understanding of this essential process has been hindered by a lack of structural information on the STI1 domain, which is essential for ubiquilin chaperone activity and phase separation. Here, we present the first crystal structure of a ubiquilin-family STI1 domain bound to a transmembrane domain (TMD), and show that ALS mutations disrupt the STI1-TMD interaction. We further demonstrate that ubiquilins contain multiple conserved internal sequences that bind to the STI1 domain, including the PXX-repeat region that is a hotspot for ALS mutations. We propose that these placeholder sequences prevent solvent exposure of the STI1 hydrophobic groove and contribute to the multivalency that drives ubiquilin phase-separation. Together, this work provides a new paradigm for understanding how STI1 domains modulate ubiquilin chaperone activity and phase separation, and offers insights into the molecular basis of ALS pathogenesis.

Indexed as

Adaptor Proteins, Signal TransducingAmyotrophic Lateral SclerosisAutophagy-Related ProteinsCell Cycle ProteinsMutationUbiquitinsCrystallography, X-RayHumansHydrophobic and Hydrophilic InteractionsModels, MolecularMolecular ChaperonesProtein BindingProtein DomainsAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsCell Cycle ProteinsMolecular ChaperonesUbiquitinsUBQLN2 protein, humanAmyotrophic Lateral SclerosisBiomolecular CondensatesMembrane ProteinsProteostasisUbiquilins

Identifiers

PMID41862640
PMCPMC13083928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.